semaglutide market Liraglutide and Share Report, 2023-2032 Semaglutide Market Size & Share,

Novo Nordisk Headquarters: Bagsvrd, Denmark Number of employees: 77,000 Year founded: 1923 Revenue (2025): $42.1 billion Forbes overall rank: 42 In 2025, Novo Nordisk reported full-year sales of about DKK 309.1 billion (roughly $45 billion), a ~6% increase in Danish kroner and ~10% at constant exchange rates, driven mainly by obesity and diabetes semaglutide products Wegovy and Ozempic, though operating profit growth was modest and weighed down by transformation costs and pricing pressures

Various systems including polymeric hydrogels [88], nanoparticles [89] and microparticles [90] have been tested in preclinical studies

Psychiatrists and other mental health professionals sound the alarm that taking GLP-1s may provoke not only distress associated with uncomfortable side effects, but unhealthy eating habits

Acknowledgements We thank Sarah Crittenden, Hannes Bulow, Alicia Melendez, and John Couchman and members of the Pocock Laboratory and for advice and comments on the manuscript

Long term effects are not known as it is only being used since past 5-6 years